Business
5N Plus doubles production capacity in semiconductor engineered materials to address growing market demand
5N Plus doubles production capacity in semiconductor engineered materials to address growi...
About this update from 5n Plus Inc.
[{"type":"text","content":"\n\n\n\n5N Plus doubles production capacity in semiconductor engineered materials to address growing market demand\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMONTRÉAL, July 31, 2018\n\n\n\nMONTRÉAL, July 31, 2018 /CNW Telbec/ - 5N Plus Inc. (TSX: VNP) (\"5N Plus\" or the \"Company\"), a leading producer of engineered materials, announced today that it is doubling the capacity of its ultra-high purity Semiconductor plant located on its Montreal campus to enable its Electronic Materials division to satisfy the growing demand for the Company's specialty semiconductor materials, which are becoming the materials of choice for advanced sensing and imaging technologies utilized in a new generation of medical devices, and in security and defense applications. The Company's strategic plan 5N21, launched in 2016, identified the specialty semiconductor sector as one of the key growth areas.  Under this plan, the Company plans to grow the revenue contribution from this sector to 15% of the Group's total revenue by 2021.  This investment is expected to be completed by mid-2019 and is included in the overall investment envelope envisioned under 5N21 which aims to deliver US$45 million Adjusted EBITDA along with 17% return on capital employed by 2021.\n\nThe portfolio of ultra-pure semiconductor engineered materials produced by 5N Plus reaches purity levels of more than 99.99999% (7N) and are increasingly being used in several sensing, imaging and opto-electronic applications across growing industries.  In the medical industry, these materials are critical for detectors in dental x-ray imaging systems, bone mineral density measurements and advanced single photon emission computed tomography (SPECT) molecular imaging systems. In the recent past, the Company has developed ultra-pure semiconductor products targeting the next generation of x-ray computed tomography (CT) medical imaging systems.  These materials enable multi-color imaging capabilities and reduction in radiation dosage; all of which are expected to markedly improve safety...